Financial Summary (All financials)
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
Revenues | 0.0 | 0.0 | 0.0 | -0.4 | -0.5 | -0.9 | 0.0 | 0.1 |
Revenue growth | | | -100.0% | -20.6% | -49.1% | -16581.5% | -91.7% | -24.3% |
Cost of goods sold | 0.7 | 0.3 | 0.0 | -0.4 | -0.5 | -0.9 | 0.0 | 0.0 |
Gross profit | -0.7 | -0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
Gross margin | -2971.1% | | | 0.0% | 0.0% | 0.0% | 92.3% | 92.3% |
Selling, general and administrative | 0.4 | 0.3 | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 | 0.1 |
Research and development | 0.8 | 0.3 | | 0.0 | 0.1 | 0.2 | 0.1 | 0.1 |
EBIT | -2.0 | -0.8 | -0.2 | -0.2 | -0.2 | -0.5 | -0.4 | -0.2 |
EBIT margin | -8270.5% | | | 50.0% | 50.0% | 50.0% | -6727.6% | -344.9% |
Pre-tax income | -2.0 | -2.8 | -0.2 | -0.2 | -0.2 | -0.5 | -0.4 | -0.3 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -2.0 | -2.8 | -0.2 | -0.2 | -0.2 | -0.5 | -0.4 | -0.3 |
Net margin | -8270.5% | | | 50.0% | 50.0% | 50.0% | -7028.8% | -394.4% |
|
Diluted EPS | ($0.02) | ($0.04) | $0.00 | $0.00 | ($0.01) | ($0.01) | ($0.02) | ($0.02) |
Shares outstanding (diluted) | 90.0 | 75.4 | 57.0 | 45.6 | 45.6 | 45.6 | 20.3 | 13.6 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|